| Literature DB >> 33311789 |
C Alston James1, Gregory A Williams2, Linda X Jin1, Jingxia Liu3, Dominic E Sanford4, Ryan C Fields5, Majella M B Doyle5, Steven M Strasberg5, William G Hawkins5, Chet W Hammill3.
Abstract
Thunderbeat™ is a device that uses both ultrasonic and advanced bipolar energies to achieve hemostasis. It has been evaluated in a variety of clinical contexts, but no literature exists regarding its application to pancreatic surgery. Using a prospective, randomized controlled trial, we evaluated its safety and efficacy in the Whipple procedure. Thirty-two participants were enrolled in the study. The Thunderbeat™ device during the Whipple procedure showed similar safety profile compared to standard of care. Copyright 2020 by the Missouri State Medical Association.Entities:
Mesh:
Year: 2020 PMID: 33311789 PMCID: PMC7721432
Source DB: PubMed Journal: Mo Med ISSN: 0026-6620